Draxxin, a tulathromycin drug sold by Zoetis, is used for respiratory diseases in cattle and pigs. The company's patent to sell this drug has expired in the US and Europe. Therefore, USFA has approved two generic tulathromycin, namely Macrosyn and Increxxa.
Bovine Respiratory Disease (BRD) and Swine Respiratory Disease (SRD) are two prevalent diseases affecting cattle and pigs. BRD affects 25% of cattle every year, increasing the fatality rate. SRD impacts the overall health of pigs and can be proven fatal. The death rate in swine has increased to 20% due to the disease.
These diseases affect the cattle and pig population on the farm and lead to a significant financial loss. Meat and dairy farmers have to bear extra expenses due to stunted animal growth, diagnosis and treatment, and higher death rate. However, the increasing rate of BRD and SRD in cattle and swine has positively affected the demand for tulathromycin, expanding the global tulathromycin market.
Draxxin contains an active ingredient of tulathromycin. The major markets of the US, Europe, Canada, and Australia had their formulation patent, which expired in February 2021. Japan has protected this active ingredient till 2023. These products are marketed in the countries like Colombia, Vietnam, Belarus, Russia, Poland, and Croatia. This provides an open door for the players to enter the market.
The growth opportunities are vast, particularly in the US and Europe. They are the most prominent markets for utilizing these anti-infection agents for BRD and SRD. This is due to the higher consumption of meat and dairy products in these regions. These reasons are anticipated to create a passage for numerous new players and offer lucrative growth opportunities, enlarging the global tulathromycin market.
Got questions about your regional growth of
Tulathromycin Market?
Just drop us a line or call on +1 646 480 7505
The coronavirus pandemic has seriously impacted all the sectors across the globe. Over 100 nations were in severe lockdown due to the outbreak. Therefore, the development of businesses was generally affected. According to the discoveries, the meat and dairy industry saw a massive loss in income because of the halfway or complete closure of the dairies or butcheries.
Many dairies were shut down in the United States when they distinguished significant flare-ups. This placed pressure, particularly on pork and beef processing. There was a 45% decrease in meat production at a certain point, leading to animals crowding on the farms. This started to increase the overheads of the farmers with no income in hand because of the lockdown.
These factors subsided the demand for various antibiotics, including tulathromycin, as the farm owners suffered financially. During this period, Zoetis saw a 15% decrease in the income produced from the sale of tulathromycin.
North America is the primary market for tulathromycin. Regardless of lodging just 5% of the population, the area holds a considerable portion of the general market. The US stands firm on a prevailing foothold in the region and the international market. The cattle population in the US decreased in 2019 due to respiratory diseases, and hence need for tulathromycin spurred in the market. Its demand is also increasing in Europe as it is widely used to treat respiratory infections in cattle and pigs.
The second biggest market of tulathromycin is in the Asia-Pacific region. In this region, China and India hold the largest share. This is due to good quality meat production. For example, China is the leading pork producer as it has half the population of pigs. According to a most recent update from China's Ministry of Agriculture and Rural Affairs, the population has seemingly increased with the start of 2022. Moreover, the nation has a solid presence of domesticated animals due to high meat consumption by the people of the country
Brazil, Mexico, Argentina, and Colombia are the biggest economies in Latin America, having the best count of cattle and pigs. Brazil has more than 51% of the regional cattle population due to the increasing demand for dairy and meat products. Over the most recent couple of years, the absolute number of bovines has quickly expanded in Brazil, and this estimation is the result of trading more meat year by year. In any case, the commonness of BRD is fundamental, which enlarges the tulathromycin market in these regions.
" Crucial Insights The Report Provides:"
* Known and Unknown Adjacencies Influencing the Growth of Market
* Explorable Revenue Sources
* Customer Behaviour Analysis
* Target Partners
* Customized Geographical Data Based on Customers as well as Competitors
* Analysis of Market Size and CAGR between the Forecast Periods